Livongo Health, a Mountain View, CA-based consumer digital health company focused on chronic conditions, raised $52.5m in a growth funding round.
The round was co-led by existing investor General Catalyst and international investment company Kinnevik and joined by Singapore-based EDBI, American Investment Holdings LLC, and Microsoft Ventures.
The company intends to use the funds to accelerate growth in diabetes management, expand to other chronic conditions, and move to international markets in 2017.
Led by Glen Tullman, Chief Executive Officer, Livongo provides a consumer digital health platform offering information, tools, and support for members to receive real-time, personalized insights and make diabetes management easier.
The company is now working to expand its solutions to support current members who have other chronic conditions such as high blood pressure and cholesterol.
To date, Livongo’s growth has been driven by adoption of its diabetes management solution among Fortune 500 companies as well as health plans, health systems, and pharmacy benefits managers.